August 6, 2025

Hyperoxia and End-Organ Complications Among Cardiogenic Shock Patients Supported by Veno-Arterial Extracorporeal Membrane Oxygenation

JWJeffrey WangUniversity of North Carolina at Chapel Hill AGApoorva GangavelliEmory University JTJoseph E. TonnaUniversity of Utah

Key Points

Severe hyperoxia is linked to higher in-hospital mortality (71.7%) among cardiogenic shock patients on VA-ECMO.
End-organ complications were more frequent in patients with severe hyperoxia, contributing to increased mortality risk.
The study analyzed 10,541 patients from a multinational cohort, stratifying outcomes based on oxygen levels.
Mediation analysis indicated that severe hyperoxia primarily affects mortality directly rather than through complications.

Abstract

Objectives: To investigate whether severe hyperoxia predisposes to end-organ complications and whether these complications contribute to in-hospital mortality among cardiogenic shock (CS) patients supported in veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Design: Adult patients with CS from the Extracorporeal Life Support Organization Registry between 2010 and 2023 were categorized into normoxia (Pa o 2 60–150 mm Hg), mild hyperoxia (Pa o 2 151–300 mm Hg), and severe hyperoxia (Pa o 2 > 300 mm Hg) based on their Pa o 2 at 24 hours. The primary outcome was in-hospital mortality. End-organ complications were analyzed using multivariate logistic regression models, and causal mediation analysis was performed to estimate the direct and indirect effects of hyperoxia on mortality. Setting: Multicenter, multinational prospective cohort study. Patients: Adults with CS supported on VA-ECMO. Interventions: Partial pressure of oxygen at 24 hours after VA-ECMO cannulation. Measurements/Main Results: A total of 10,541 patients were included (normoxia: 48.4%, mild hyperoxia: 30.0%, severe hyperoxia: 21.5%). There was higher in-hospital mortality in patients with severe hyperoxia (71.7%, adjusted OR aOR: 2.17; 95% CI, 1.19–2.50) and mild hyperoxia (63.8%, aOR: 1.34; 95% CI, 1.19–1.50) compared normoxia (52.7%; referent group). Severe hyperoxia was associated with more end-organ complications, which incrementally predicted higher mortality (aOR: 1.42; 95% CI, 1.25–1.61). Mediation analysis demonstrated that hyperoxia primary exerted a direct effect on mortality (86%), with contributions from neurologic (3.1%), hepatic (3.9%), renal (3.5%), and bleeding (2.3%) complications. Conclusions: Severe hyperoxia in patients with CS receiving VA-ECMO is associated with increased mortality and more end-organ complications. However, most of the effect of severe hyperoxia on mortality occurs via direct effects, independent of end-organ complications. These findings highlight the potential direct toxicity of hyperoxia and underscore the need for strategies to optimize oxygen delivery in this critically ill population.

Ask AI

Helpful

Bookmark

View Full Paper